A federal jury in California ruled Friday that Apple must pay medical device maker Masimo $634 million for infringing a patent on blood oxygen-monitoring technology. Reuters reports the jury found ...

Masimo Corp. ((MASI)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...

In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones The INSPIRE Trial Prospectively Assesses Pulse ...

“There is nothing more important than keeping patients safe, especially when time is of the essence,” said Julie Foster, president of Front Line Care at Baxter. “Care teams rely on vital signs ...

Designed for optimized workflows to support earlier detection of patient deterioration Future-ready device features customizable configurations and upgrade capabilities Connects to Baxter’s ...

A few days ago, Masimo sued U.S. Customs over its decision to let Apple resume selling the Apple Watch in the United States with the blood oxygen feature enabled. Now, the government agency has ...

For millions of Apple Watch Series 9, Series 10 and Ultra 2 users who didn’t have the blood oxygen monitoring (SpO2) feature on their smartwatches, last week’s software updates offered a key ...

“According to Masimo, the CBP ‘inexplicably reversed course’ from its prior rulings in finding that Apple could overcome the LEO by shipping its smartwatches separately from iPhones.” On Wednesday, ...

Good afternoon, ladies and gentlemen, and welcome to Masimo's Second Quarter 2025 Earnings Conference Call. The company's press release is available at www.masimo.com. [Operator Instructions] I'm ...